303 related articles for article (PubMed ID: 18321945)
1. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA).
Ohlsson V; Baildam E; Foster H; Jandial S; Pain C; Strike H; Ramanan AV
Rheumatology (Oxford); 2008 Apr; 47(4):555-6. PubMed ID: 18321945
[No Abstract] [Full Text] [Related]
2. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
3. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
[TBL] [Abstract][Full Text] [Related]
4. Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease.
Woo P
Ann Rheum Dis; 2008 Mar; 67(3):281-2. PubMed ID: 18292104
[No Abstract] [Full Text] [Related]
5. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Nigrovic PA; Mannion M; Prince FH; Zeft A; Rabinovich CE; van Rossum MA; Cortis E; Pardeo M; Miettunen PM; Janow G; Birmingham J; Eggebeen A; Janssen E; Shulman AI; Son MB; Hong S; Jones K; Ilowite NT; Cron RQ; Higgins GC
Arthritis Rheum; 2011 Feb; 63(2):545-55. PubMed ID: 21280009
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series.
Record JL; Beukelman T; Cron RQ
J Rheumatol; 2011 Jan; 38(1):180-1. PubMed ID: 21196588
[No Abstract] [Full Text] [Related]
7. Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis.
Mirkinson LJ; Nagle D; Kadom N; Jones OY
J Clin Rheumatol; 2006 Apr; 12(2):83-6. PubMed ID: 16601542
[TBL] [Abstract][Full Text] [Related]
8. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
Verbsky JW; White AJ
J Rheumatol; 2004 Oct; 31(10):2071-5. PubMed ID: 15468378
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.
Swart JF; Barug D; Möhlmann M; Wulffraat NM
Expert Opin Biol Ther; 2010 Dec; 10(12):1743-52. PubMed ID: 20979564
[TBL] [Abstract][Full Text] [Related]
10. [New treatments for idiopathic juvenile arthritis].
Bader-Meunier B; Quartier P
Arch Pediatr; 2009 Dec; 16(12):1607-11. PubMed ID: 19896351
[TBL] [Abstract][Full Text] [Related]
11. Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis?
de Benedetti F; Martini A
Arthritis Rheum; 2005 Mar; 52(3):687-93. PubMed ID: 15751082
[No Abstract] [Full Text] [Related]
12. A case of macrophage activation syndrome successfully treated with anakinra.
Kelly A; Ramanan AV
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
[No Abstract] [Full Text] [Related]
14. Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).
Hedrich CM; Bruck N; Fiebig B; Gahr M
Rheumatol Int; 2012 Nov; 32(11):3525-30. PubMed ID: 22083619
[TBL] [Abstract][Full Text] [Related]
15. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
16. When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
Prince FH; Twilt M; Simon SC; van Rossum MA; Armbrust W; Hoppenreijs EP; Kamphuis S; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; ten Cate R; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 Jul; 68(7):1228-9. PubMed ID: 19525408
[No Abstract] [Full Text] [Related]
17. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
[No Abstract] [Full Text] [Related]
18. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
20. Juvenile idiopathic arthritis presenting with prolonged fever.
Yeh TL; Huang FY; Shyur SD; Chen TL; Lee CS; Huang DT
J Microbiol Immunol Infect; 2010 Jun; 43(3):169-74. PubMed ID: 21291842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
